The electrophysiological study in MG with nAChR antibodies reported that compensatory ACh-release is upregulated but cannot be sustained at the high-frequency of nerve stimulation, possibly because of reduced pool of releasable ACh-containing vesicles [9,76]. The gene discussed is CHRNA4; the disease is myasthenia gravis.